Title
Preexposure Prophylaxis: An Emerging Clinical Approach To Preventing Hiv In High-Risk Adults
Keywords
AIDS; Emtricitabine/tenofovir disoproxil fumarate; HIV; Preexposure prophylaxis therapy; Prevention; Sexually transmitted infection
Abstract
The HIV antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) was recently approved as preexposure prophylaxis (PrEP) therapy for adults at high risk for sexually acquired HIV infection. This article reviews the data supporting the efficacy of PrEP, and provides other relevant data regarding the implementation of PrEP.
Publication Date
1-1-2014
Publication Title
Nurse Practitioner
Volume
39
Issue
9
Number of Pages
50-53
Document Type
Review
Personal Identifier
scopus
DOI Link
https://doi.org/10.1097/01.NPR.0000452976.92052.fa
Copyright Status
Unknown
Socpus ID
84907985617 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/84907985617
STARS Citation
Blackwell, Christopher W., "Preexposure Prophylaxis: An Emerging Clinical Approach To Preventing Hiv In High-Risk Adults" (2014). Scopus Export 2010-2014. 9575.
https://stars.library.ucf.edu/scopus2010/9575